These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 24659657)
1. Neuron specific enolase and prognosis of non-small cell lung cancer: a systematic review and meta-analysis. Yan HJ; Tan Y; Gu W J BUON; 2014; 19(1):153-6. PubMed ID: 24659657 [TBL] [Abstract][Full Text] [Related]
2. Serum neuron-specific enolase levels were associated with the prognosis of small cell lung cancer: a meta-analysis. Zhao WX; Luo JF Tumour Biol; 2013 Oct; 34(5):3245-8. PubMed ID: 23775010 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer. Yan P; Han Y; Tong A; Liu J; Wang X; Liu C Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34286335 [TBL] [Abstract][Full Text] [Related]
4. [Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer]. Chen Y; Peng W; Huang Y; Chen J; Su G; Jiang C; Xiao Y Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):508-11. PubMed ID: 26463326 [TBL] [Abstract][Full Text] [Related]
5. Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations. Suh KJ; Keam B; Kim M; Park YS; Kim TM; Jeon YK; Kim DW; Chung DH; Kim YW; Heo DS Clin Lung Cancer; 2016 Jul; 17(4):245-252.e1. PubMed ID: 26719155 [TBL] [Abstract][Full Text] [Related]
6. Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer. Tiseo M; Ardizzoni A; Cafferata MA; Loprevite M; Chiaramondia M; Filiberti R; Marroni P; Grossi F; Paganuzzi M Anticancer Res; 2008; 28(1B):507-13. PubMed ID: 18383893 [TBL] [Abstract][Full Text] [Related]
7. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer. Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607 [TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer. Nisman B; Heching N; Biran H; Barak V; Peretz T Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis. Tian Z; Liang C; Zhang Z; Wen H; Feng H; Ma Q; Liu D; Qiang G World J Surg Oncol; 2020 May; 18(1):116. PubMed ID: 32473655 [TBL] [Abstract][Full Text] [Related]
10. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer. Dong Y; Zheng X; Yang Z; Sun M; Zhang G; An X; Pan L; Zhang S J Cancer Res Ther; 2016 Oct; 12(Supplement):34-36. PubMed ID: 27721249 [TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of serum neuron-specific enolase in non-small cell lung cancer]. Kimura H; Yamaguchi T; Nishino K; Nakagawa M; Yokota S; Nishikawa H; Ito M; Ogura T Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):128-32. PubMed ID: 9617138 [TBL] [Abstract][Full Text] [Related]
12. Value of serum neuron-specific enolase in nonsmall cell lung cancer. Diez M; Torres A; Ortega L; Maestro M; Hernando F; Gomez A; Picardo A; Granell J; Balibrea JL Oncology; 1993; 50(2):127-31. PubMed ID: 8383830 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of serum tumor markers in patients with lung cancer. Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM Respiration; 2002; 69(1):25-9. PubMed ID: 11844959 [TBL] [Abstract][Full Text] [Related]
15. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer. van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221 [TBL] [Abstract][Full Text] [Related]
16. Clinical implications for pro-GRP in small cell lung cancer. A single center experience. Cavalieri S; Morelli D; Martinetti A; Galli G; Nichetti F; de Braud F; Platania M Int J Biol Markers; 2018 Jan; 33(1):55-61. PubMed ID: 28967066 [TBL] [Abstract][Full Text] [Related]
17. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase. Giovanella L; Ceriani L; Bandera M; Garancini S Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956 [TBL] [Abstract][Full Text] [Related]
18. [Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer]. Shibayama T; Ohnoshi T; Ueoka H; Horiguchi T; Kodani T; Segawa Y; Maeda T; Miyatake K; Takigawa N; Kimura I Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1097-102. PubMed ID: 1324376 [TBL] [Abstract][Full Text] [Related]
19. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer]. Wei T; Luo RC; Zuo Q; Zhang JY; Miao JX; Lu HF Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621 [TBL] [Abstract][Full Text] [Related]
20. The role of neuron-specific enolase (NSE) and thymidine kinase (TK) levels in prediction of efficacy ofEGFR-TKIs in patients with advanced-stage NSCLC [corrected]. Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z; Topolcan O Anticancer Res; 2014 Sep; 34(9):5193-8. PubMed ID: 25202114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]